Katherine Gill
Katherine Gill is a prominent researcher collaborating with the Desmond Tutu Health Foundation, focusing on HIV prevention strategies. Her work has been pivotal in demonstrating the efficacy of lenacapavir, a long-acting anti-HIV injection, particularly among vulnerable populations such as teens and young women. Gill's contributions to the field have been crucial in shaping strategies to combat the HIV epidemic in South Africa and beyond.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| South Africa | 1 | 7.00 | 0.45% | +0% | 59,308,690 | 268,365 | $350,000 | 1,584$ |
| Totals | 1 | 59,308,690 | 268,365 | $350,000 | 1,584$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
South Africa:
Katherine Gill works with Linda-Gail Bekker and revealed the results of a study showing lenacapavir's effectiveness in young people.
7